Percutaneous vertebroplasty with low-dose bone cement for acute osteoporotic vertebral compression fractures
10.3969/j.issn.2095-4344.2014.12.002
- VernacularTitle:改良小剂量骨水泥椎体成形治疗急性骨质疏松性压缩骨折
- Author:
Cai CHENG
;
Lu WANG
;
Shukui LI
- Publication Type:Journal Article
- Keywords:
biocompatible materials;
vertebroplasty;
osteoporotic fractures;
acrylic resins
- From:
Chinese Journal of Tissue Engineering Research
2014;(12):1811-1816
- CountryChina
- Language:Chinese
-
Abstract:
BACKGROUND:Percutaneous vertebroplasty technique has become an effective means for clinical treatment of spinal osteoporotic fractures, but there is the risk of bone cement leakage.
OBJECTIVE:To explore the clinical effect of percutaneous vertebroplasty with low-dose bone cement for acute osteoporotic vertebral compression fractures.
METHODS:From September 2008 to February 2011, 32 patients with osteoporotic compression fractures were treated by percutaneous vertebroplasty. According to the dose of bone cement, the patients were divided into low dose group (2-4 mL) and routine dose group (4-6 mL). In addition, another patients who were hospitalized over the same period for acute osteoporotic compression and could not receive vertebroplasty due to urgical contraindication served as control group.
RESULTS AND CONCLUSION:The pain relief and vertebral height restoration rate of the low dose group and routine dose group were significantly better than the control group (P<0.05). The bone cement leakage rate and last fol ow-up incidence of adjacent segment vertebral fractures of the low dose group were also significantly lower than those in the routine dose group (P<0.05). Vertebroplasty with modified low dose bone cement can achieve satisfactory clinical effects, and effectively reduce the leakage of bone cement and incidence of adjacent segment secondary fractures.
